GARCINIA CAMBOGIA 500 mg
Food supplement declared in France, declaration No 2021-8-710, decision dated 16 August 2021
GARCINIA CAMBOGIA 500 mg, from SARL COSBASE, is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Garcinia gummi-gutta 2,500 mg per day. 1 point in its composition requires a check (prohibited substance, dose or novel food).
- Brand
- not provided
- Food business operator placing the product on the market
- SARL COSBASE
- Status
- Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
- Form
- Capsule
- Daily dose
- 5 gélules par jour
- Directions for use
- 5 gélules par jour
Declaration 308831, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Garcinia gummi-gutta (L.) Roxb. | Fruit (écorce) | Extrait sec aqueux | 2,500 mg |
Additives
E464, E470b
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Regulatory points
- Substance interdite
Contains the plant Garcinia cambogia (Garcinia gummi-gutta). In France, importing and placing food supplements containing it on the market are suspended until 17 April 2027 (arrêté du 16 avril 2026).
Source: French orders suspending food supplements containing a plant (Official Journal), checked against the text, arrêté du 16 avril 2026 (JORFTEXT000053907152).
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Garcinia gummi-gutta (L.) Roxb.
Read the warning, when it applies and the studies cited
MALABAR TAMARIND - GARCINIA GUMMI-GUTTA
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a liver disorder (HC 2025).
Sources cited by Health Canada (2)
- HC 2025: Health Canada: Summary Safety Review - Garcinia gummi-gutta and Hydroxycitric Acid - Assessing the Potential Risk of Hepatotoxicity. Available from: https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR1755272782909
- SC 2025 : Santé Canada : Résumé de l'examen de l'innocuité - Garcinia gummi-gutta et acide hydroxycitrique - Évaluation du risque potentiel d'hépatotoxicité. Disponible à : https://pmps.hpfb-dgpsa.ca/documents-d-examen/ressource/SSR1755272782909
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking medications (HC 2025).
Sources cited by Health Canada (2)
- HC 2025: Health Canada: Summary Safety Review - Garcinia gummi-gutta and Hydroxycitric Acid - Assessing the Potential Risk of Hepatotoxicity. Available from: https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR1755272782909
- SC 2025 : Santé Canada : Résumé de l'examen de l'innocuité - Garcinia gummi-gutta et acide hydroxycitrique - Évaluation du risque potentiel d'hépatotoxicité. Disponible à : https://pmps.hpfb-dgpsa.ca/documents-d-examen/ressource/SSR1755272782909
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if you experience any new symptoms including yellowing of the eyes or skin, dark urine, nausea, vomiting, stomach pain (HC 2025).
Sources cited by Health Canada (2)
- HC 2025: Health Canada: Summary Safety Review - Garcinia gummi-gutta and Hydroxycitric Acid - Assessing the Potential Risk of Hepatotoxicity. Available from: https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR1755272782909
- SC 2025 : Santé Canada : Résumé de l'examen de l'innocuité - Garcinia gummi-gutta et acide hydroxycitrique - Évaluation du risque potentiel d'hépatotoxicité. Disponible à : https://pmps.hpfb-dgpsa.ca/documents-d-examen/ressource/SSR1755272782909
Contraindications
Condition of application: All products.
Do not use if you are pregnant (HC 2010).
Sources cited by Health Canada (2)
- HC 2010: Health Canada: Prenatal Nutrition Guidelines for health Professionals: Gestational weight gain [Accessed 2024 April 7]. Available from: https://www.canada.ca/content/dam/hc-sc/migration/hc-sc/fn-an/alt_formats/pdf/nutrition/prenatal/ewba-mbsa-eng.pdf
- SC 2010 : Santé Canada : Lignes directrices sur la nutrition pendant la grossesse à l'intention des professionnels de la santé : Gain de poids pendant la grossesse. [Consulté le 7 avril 2024]. Disponible à : https://www.canada.ca/content/dam/hc-sc/migration/hc-sc/fn-an/alt_formats/pdf/nutrition/prenatal/ewba-mbsa-fra.pdf
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Other declarations with the same name
In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.
- Garcinia Cambogia 500mg ABDOULAYE WAGUE, declared in 2017 : different composition: 2 ingredient(s) added, 2 missing
- Garcinia Cambogia 500 mg SARL COSBASE, declared in 2017, earlier declaration, replaced by the 2021 declaration : different composition: 2 ingredient(s) added, 1 missing
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “GARCINIA CAMBOGIA 500 mg: composition and regulation”, https://compoatlas.com/en/supplements/products/308831-garcinia-cambogia-500-mg, updated 15 November 2026.